Navigation Links
NuvaRing Lawsuit News: Rottenstein Law Group Responds to Judge’s Refusal to Dismiss Punitive Damages Claims
Date:5/6/2013

(PRWEB) May 06, 2013

Two weeks after a judge threw out seven bellwether NuvaRing lawsuits, plaintiffs scored a win on May 3 in the New Jersey multicounty litigation consolidation when a judge refused to dismiss punitive damages claims in nine bellwether NuvaRing lawsuits, according to court documents. The Rottenstein Law Group, a NuvaRing law firm, offers its opinion on the developments and notes that it operates a case information site that features a comprehensive history of the contraceptive device, in addition to how to go about filing a lawsuit.

Attorneys for medical device manufacturers Merck and Organon USA argued that punitive damages could not be sought in New Jersey because the state’s Product Liability Act excludes punitive damages in prescription drug litigation, according to court documents in In re: NuvaRing Litigation (BER-L-3081-09, Superior Court of New Jersey, Bergen County). Judge Brian R. Martinotti said the cases are primarily concerned with what the companies revealed to the plaintiffs and their doctors in each of the respective states—not what was disclosed to the U.S. Food and Drug Administration in warning labels issued from the companies’ headquarters in New Jersey. This, he said, meant that each of those respective states had an interest in regulating punitive damages differently.

“The ruling does not guarantee any particular outcome after trial,” said Rochelle Rottenstein, principal of the Rottenstein Law Group, “but it does mean that plaintiffs’ attorneys are allowed to seek punitive damages in addition to compensatory damages.”

This news comes as parties on both sides are also preparing for bellwether trials in the federal multidistrict litigation, a consolidation of federal NuvaRing lawsuits (MDL-1964, U.S. District Court for the Eastern District of Missouri), set to begin in October.

There are about 200 NuvaRing lawsuits pending in the MCL in New Jersey. There are currently more than 1,000 lawsuits pending as part of the federal MDL, according to court records. Among the side effects cited by plaintiffs is the risk of blood clots. The British Medical Journal published a study that found a six-and-a-half-fold to eightfold increase in the risk of clots in women who use vaginal ring contraceptives.*

The Rottenstein Law Group encourages those women who believe their NuvaRing contraceptive device has injured them to visit its NuvaRing Lawsuit Information Center. The website offers updates on NuvaRing news, a history of the device and information on how to file a NuvaRing lawsuit.

*bmj.com/content/344/bmj.e2990

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and drugs. (Attorney advertising. Prior results do not guarantee a similar outcome.)

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com
                            ###

Read the full story at http://www.prweb.com/releases/side-effects-nuvaring/nuvaring-birth-control/prweb10704689.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Law Firm Aggressively Litigating against Birth Control Makers for their Newer, but Allegedly Unsafer Products: Nuvaring, Yaz, BeYaz, Yasmin, Ocella, Gianvi
2. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
3. DrugRisk Update: NuvaRing Lawsuit Trials to Begin This Year
4. NuvaRing Blood-Clotting Victims Still Eligible to File Lawsuits Through Resource4thePeople
5. NuvaRing Lawsuit Filed on Behalf of a South Carolina Woman who Developed Two Blood Clots While Using NuvaRing, Reports Wright & Schulte LLC
6. Federal NuvaRing Blood-Clotting Lawsuits Report: Resource4thePeople Updates Consumers with News That First Bellwether Trial Rescheduled to July
7. NuvaRing Blood-Clotting Claims Now Being Investigated by Resource4thePeople Attorneys
8. DrugRisks Center NuvaRing Lawsuit News: Drug Maker May Have Concealed Risks
9. 2013 NuvaRing Blood-Clotting Allegations Inquiries Eligible for Review by Resource4thePeople Attorneys
10. Rescheduling of First NuvaRing Lawsuit Trials in State, Federal NuvaRing Lawsuit Litigation, Reports Wright & Schulte LLC
11. First NuvaRing Lawsuits in State, Federal NuvaRing Litigations Set to Head to Trial Later This Year, Alonso Krangle LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Last night, Christine Collins of ... Year for her extraordinary compassion and lifelong dedication to serve others. Since 1997, ... for the prestigious award each year – identifying a CAREGiver who has exemplified ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Offering the ... with an oil many times purer and more potent than the market has seen ... of Gstaad, Switzerland, as well as a patented chromatography process for extraction, to produce ...
(Date:4/26/2017)... ... April 26, 2017 , ... Jump Technologies, Inc., an innovative ... has completed a round of funding to accelerate its growth strategies. The $3.5 ... Capital is a growth equity firm focused on investments in healthcare and technology ...
(Date:4/26/2017)... ... April 26, 2017 , ... ... the ATA 2017 President’s Awards recipients, comprised of organizations and individuals who ... , The ATA 2017 President’s Awards recognize individuals and organizations on ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and Markets ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ... offering. ... drug delivery technologies will rise from USD 20 Billion in 2015 ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables ...
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/19/2017)... -- The Mobile X-Ray product segment is the most attractive ... forecast period Mobile X-Ray segment is the largest ... devices market, which is estimated to be valued at more ... of 7% over the forecast period. Mobile X-Ray segment is ... 100 Mn in 2017 over 2016. The segment,s revenue in ...
Breaking Medicine Technology: